Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

Also called NCT03892824

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Javelin Medical (from the registry)
Registry
  • NCT NCT03892824
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, Czechia, Germany, Greece, Hungary, Israel, Poland, Spain (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03892824. Allocation not applicable; no masking; primary purpose prevention. Start 2019-04-15 (actual); primary completion 2024-10-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
Acronym
CAPTURE2
Condition
Stroke
Intervention (Device)
Vine™ Embolic Protection System
Lead sponsor
Javelin Medical (class: industry)
Collaborator
Genae (class: industry)

Record details

Record id
cardio:ct-nct03892824
Content hash
fce3de5ddb79c8180c961d4215dab5fe3bde3dd20f9185228a0b6913a5d37dfc